6550--Intent to Sole Source: Cepheid GeneXpert Infinity Molecular Reagents IDIQ
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36C24826Q0193
- Agency
- Veterans Integrated Service Network 8 Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Department of Veterans Affairs Bay Pines VA Healthcare System Bay Pines FL 33744, United States
- Points of contact
-
- Moneque Rodriguez moneque.rodriguez@va.gov (813) 550-9486
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 is issuing a pre-solicitation notice for Cepheid GeneXpert Infinity molecular reagents used for infectious disease testing. The procurement covers reagent kits for detecting nine categories of pathogens, including MRSA, Clostridioides difficile toxin, carbapenem-resistant Enterobacteriaceae, Chlamydia trachomatis/Neisseria gonorrhoeae, Group A Streptococcus, SARS-Coronavirus-2, Hemophilus influenzae, respiratory syncytial virus, and vaginal infection organisms. The Government intends to award this as a sole source, fixed-price, single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract based on the determination that only Cepheid can fulfill the requirement due to the proprietary and specialized nature of the reagents and their exclusive compatibility with the GeneXpert Infinity analyzer already owned by the facility. The evaluation will focus on whether competing sources can demonstrate equivalent capability to meet the agency's needs. All interested and capable sources are invited to submit evidence of their ability to fulfill the requirement by February 20, 2026 at 1:00 PM Eastern Time to the Contracting Officer, Moneque Rodriguez, at moneque.rodriguez@va.gov.
This procurement includes no set-aside designations and anticipates a sole source award to Cepheid, the current and only authorized provider of these reagents. The estimated ceiling value for the contract is $3,500,000.00 over a 3.5-year period spanning April 1, 2026 through September 30, 2029, divided into four annual periods. Annual estimated usage ranges from 10 to 500 units per test type across the nine reagent categories. A Sources Sought notice was previously issued from December 18, 2025 through January 9, 2026, which generated no relevant competing responses, supporting the sole source justification. The procurement falls under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) and PSC code 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets), and the sole source determination was approved by the Head of Contracting Activity, East, on February 2, 2026.
Notice text
This Notice of Intent is provided to advise that the Government intends to solicit and negotiate a Sole Source, Fixed-Priced Single Award Indefinite Delivery Indefinite Quantity (IDIQ) with only one source, Cepheid. This procurement is for an extensive range of infectious disease testing covering microorganisms such as Methicillin Resistant Staph aureus (MRSA), Clostridioides (Clostridium) difficile Toxin (C diff), Carbapenemase Resistant Enterobacteriaceae (CRE), Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG), Beta hemolytic Streptococcus Group A (Streptococcus pyogenes), SARS-Coronavirus-2, Hemophilus influenzae (influenza A and influenza B), Respiratory syncytial virus (RSV), and Vaginal Infection Molecular Test to be used on the Cepheid GeneXpert Infinity that is owned by the facility.
This action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of Revolutionary FAR Overhaul 12.102 (b) and 41 USC §1901, only one will meet the Government s needs. Only one source is capable of responding due to the unique or specialized nature of the supplies and/or services. It is the Government s belief that the proposed candidate is the only authorized provider of the reagents that can meet the agency s needs. Interested persons may identify their interest and capability to respond to the requirement. All responsible sources may submit a quotation, bid, or proposal, as appropriate, which will be considered by the agency.
This notice of intent is not a request for competitive proposals and no solicitation is available. Any responses received will only be considered for the purposes of determining whether to conduct a competitive procurement in lieu of sole source contract described in this notice, and such determination shall be made at the sole discretion of the Government. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the requirement. If no responses are received, the government will proceed with the Sole Source acquisition. Any response should be emailed to Moneque Rodriguez at moneque.rodriguez@va.gov by 13:00PM Eastern Standard Time on February 20, 2026.
Attachments
| File | Type | Posted |
|---|---|---|
| SSJ 36C248-26-AP-1635p_Redacted.pdf | ||
| 36C24826Q0193_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6550--Cepheid GeneXpert Infinity Molecular Reagents IDIQ | Award Notice | |
| 6550--Intent to Sole Source: Cepheid GeneXpert Infinity Molecular Reagents IDIQ | Solicitation | |
| 6550--Intent to Sole Source: Cepheid GeneXpert Infinity Molecular Reagents IDIQ | Pre-Solicitation | |
| 6550--Sources Sought: Cepheid GeneXpert Infinity Reagents | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity